Lupus & antiphospholipid syndrome
Association of podocyte injury with clinical features and prognosis in patients with mesangial proliferative lupus nephritis
Authors' conclusion
Our data identified Class II LN patients with podocyte injury (FPE ≥ 50%) present prominent renal damage and higher rate of renal relapse
Study context
- Population
- Patients with mesangial proliferative (Class II) lupus nephritis (LN) screened from 576 LN patients with renal biopsyfrom 576 LN biopsies
- Participants
- 58 patients
- Exposure
- Four Class II LN groups by podocyte damage and immune complex (IC) deposits
Methodological detailsclinicopathologic analysis
- Clinicopathologic analysis
Main finding
As reported in the abstract
- Significant difference in ages among the four groups; onset age significantly later with FPE ≥ 50%
- Thrombocytopenia frequency differed among the four groups; lower with FPE ≥ 50%
- FPE ≥ 50%: lower serum albumin and eGFR, elevated proteinuria and serum lipids
- Renal relapse rates differed among the four groups; recurrence rate higher in the FPE ≥ 50% group
Observational data: associations, not effects.
Further findings
Treatment
- Most received GC plus immunosuppressants; ACEI/ARB use highest in the Podocyte Injury group
Original publication
Association of podocyte injury with clinical features and prognosis in patients with mesangial proliferative lupus nephritis. Lupus. Published 2 December 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →